TY  - JOUR
AU  - Rodriguez-Peralvarez, Manuel
AU  - Amado, Victor
AU  - de la Mata, Manuel
PY  - 2019
DO  - 10.1111/apt.15300
UR  - http://hdl.handle.net/10668/14335
T2  - Alimentary pharmacology & therapeutics
AB  - We read with great interest the meta‐analysis by Grigg et al,1  which evaluated the role of the mechanistic target of rapamycin (mTOR) inhibitors (sirolimus or everolimus) in patients with hepatocellular carcinoma (HCC) undergoing liver...
LA  - en
PB  - Wiley-Blackwell Publishing
KW  - Carcinoma, hepatocellular
KW  - Everolimus
KW  - Humans
KW  - Liver neoplasms
KW  - Liver transplantation
KW  - Sirolimus
TI  - Letter: mechanistic target of rapamycin inhibitors as adjuvant therapy for patients with hepatocellular carcinoma undergoing liver transplantation.
TY  - Research article
VL  - 50
ER  -